In a surprise, Hans Bishop takes over as CEO of Grail, the liquid biopsy startup
JUNO THERAPEUTICS
Bishop, who led Juno until it was sold to Celgene, will be the third chief executive Grail has had since it was founded in 2015.
Clinical and Molecular Allergy
Hace 7 horas
No hay comentarios:
Publicar un comentario